New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Mammalian & mAbs

AGC Biologics FDA Commercial Approval Copenhagen

2 min read

AGC Biologics Strengthens Portfolio with Latest FDA Commercial Approval at Company’s CPH Facility

August 27, 2024 at 11:05 AM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics' Seattle Headquarters

1 min read

AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications

July 29, 2024 at 6:30 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

Essential Pharma and AGC Biologics Partner on late-phase clinical manufacturing of immunotherapy candidate for the treatment of high-risk neuroblastoma

June 17, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics Copenhagen officially opens their new facility expansion.

2 min read

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

June 4, 2024 at 12:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics is partnering with BioConnection to simplify the path to DP for biologics projects.

2 min read

AGC Biologics and BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

May 22, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Illustration of new AGC Biologics Yokohama Site

1 min read

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan

April 25, 2024 at 5:53 AM
Mammalian & mAbs Press Release Business Updates mRNA Content
Read press release
AGC Biologics and VAR2 Pharmaceuticals Completion of antibody late stage clinical work

1 min read

AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals

April 23, 2024 at 8:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
AGC Biologics new manufacturing facility - Yokohama, Japan

1 min read

AGC Biologics announces plans for New Manufacturing Site in Yokohama Japan

January 4, 2024 at 6:01 AM
Cell & Gene Therapy Mammalian & mAbs Press Release Business Updates mRNA Content
Read press release
Asahi Kasei Pharma is partnering with AGC Biologics

1 min read

AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project

August 15, 2023 at 3:00 PM
Mammalian & mAbs Press Release Business Updates
Read press release
Winner certificate for AGC Biologics being awarded the Bioprocessing Excellence in Japan award.

1 min read

AGC Biologics Receives Bioprocessing Excellence Award in Japan for Work at Chiba Site

April 25, 2023 at 5:00 PM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
1 2 Next